LC
Therapeutic Areas
Guangzhou Baiyunshan Pharmaceutical Holdings Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Jinhao Jiemei Tablets | Anti-tumor (Adjuvant Therapy) | Approved |
| Baiyunshan Banlangen Granules | Cold, Flu, Viral Infection | Marketed |
| Novel Chemical Entity - Oncology | Solid Tumors | Phase I |
| Biosimilar Development Program | Autoimmune Diseases (e.g., Rheumatoid Arthritis) | Preclinical |